Updated September 14, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Enlivex Therapeutics is 53 — signals are mixed heading into the print. Underlying trend: 1 of 4 tracked signals trending up over the last 3 months.
Enlivex Therapeutics (ENLV) is trading at $0.96, down 89.8% over the last 3 months (from $9.45 three months ago).
Trends across the last 3 months — the run-up to Enlivex Therapeutics’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 0 | No 3-month baseline |
| LinkedIn headcount | 38 | → +2.7% |
| Web traffic | 5,886 | ↑ +59.9% |
| Employee business outlook | 0% Negative | → flat |
| X followers | 129 | → +0.0% |
Full daily-resolution trend charts on every signal are on the ENLV ticker page.
AltIndex stock alerts fire when alt-data on ENLV breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Enlivex Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in